Press Releases

London, UK – 30 October 2025 – SAE Media Group has officially unveiled the agenda for the 7th Annual AI in Drug Discovery conference, taking place 9–10 March 2026 at the Hilton London…
Read More...

Tokyo - February 26-27, 2026 - The Targeted Therapies Partnering & Licensing Summit Asia is set to unite industry leaders, investors, and biopharma innovators across the region to…
Read More...

SAE Media Group unveils the full agenda for AI in Drug Discovery Conference 400 ticket saving ends 7 November 2025. 2026, highlighting the technologies and strategies driving …
Read More...

Boston, MA | October 9, 2025 - Following the success of the inaugural LEAN Cell & Gene Summit in Boston, the event series is set to continue in National Harbor, Maryland, on…
Read More...

Boston, MA (September 22, 2025) & Washington, D.C. (November 6, 2025). The LEAN Cell & Gene Summit series, co-organised by ScaleReady, and Hanson Wade, is proud to unveil its…
Read More...

The 3rd Spatial Biology for Drug Development Summit Boston, MA | October 22-23, 2025 *Free to Attend for Biopharma Experts Spatial biology is at a turning point. Advances in…
Read More...

The 2025 summit offers an in-depth look at the most innovative technologies and scientific strategies shaping the future of microbiome-based therapies. This includes advancements in…
Read More...

One of the most valuable aspects of the Microbiome Movement Summit is its emphasis on meaningful connections. With over 8 hours of structured networking built into the agenda, attendees…
Read More...

As part of the 10th anniversary celebrations, the 2025 Microbiome Movement Summit will host the Microbiome Movement Awards ceremony—a new special feature for the 10th annual summit.…
Read More...

A standout feature of the summit is the highly anticipated Start-Up Showcase, which gives early-stage biotech companies a dedicated platform to present their visionary work to a panel…
Read More...

The Microbiome Movement Summit returns in 2025 for its milestone 10th edition, marking a decade of groundbreaking progress and collaborative advancement in microbiome science. This…
Read More...

LONDON, UK – 24–25 June 2025 Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution? From complex…
Read More...

AdvanCell has amassed a great amount of funding recently from $18M in Federal Funding just this week and $112M Series C Financing. What led such financing? We received non-dilutive…
Read More...

Gain insights into the cutting-edge innovation in in vivo and in vitro tumour modelling, discover strategies to de-risk your studies, and learn how to refine your drug development…
Read More...

With the 5th Genome Editing Therapeutics Summit just three weeks away, anticipation is building! On December 3-5, Gene Editing experts will join together to spearhead the development,…
Read More...

Taking place during the 15th World ADC San Diego, the  11th World ADC Awards reunited both newcomers and leaders of the antibody-drug conjugate industry this November 6, 2024.…
Read More...

This week marks your last chance to save up to $350 on your ticket to 5th Genome Editing Therapeutics Summit (formerly known as CRISPR 2.0). With industry giants like Beam,…
Read More...

In a few weeks’ time, industry’s foremost drug developers will be convening at the 5th Genome Editing Therapeutics Summit* (December 3-5 | Boston, MA), the only industry meeting…
Read More...

The 5th Genome Editing Therapeutics Summit (formerly the CRISPR 2.0 Summit) this December will be your foremost drug development focused gene editing meeting, providing you with the…
Read More...

Genome editing represents one of the most significant recent advancements in molecular biology. CRISPR/Cas9 has been seen by many as cutting-edge (if you can pardon the pun) for its…
Read More...